Video/ Infection Control

'Superbug' fungus emerging in N.Y. region

Two of the three kinds of commonly used antifungal drugs have little effect


The "superbug" fungus, Candida auris, is emerging as a new menace in U.S. hospitals, mostly in New York and New Jersey, according to an article and video on the AP website.
 
Two of the three kinds of commonly used antifungal drugs have little effect on C. auris
 
Infections related to the fungas tend to be diagnosed in patients after they've been in hospitals for several weeks. The fungus can infect wounds, ears and the bloodstream.
 
A recent study found the fungus on surfaces in hospital rooms and on the skin of nurses and patients — even after patients were treated with antifungal medications.
 
 



May 5, 2017


Topic Area: Infection Control


Recent Posts

Streamlined Integrated Project Delivery Tackles Design Challenges

Successful implementation of IPD Light can improve patient care, project outcomes and bottom lines.


Encompass Health Rehabilitation Hospital of Central Florida - Sumter County Opens

It is a satellite location of Encompass Health Rehabilitation Hospital of Central Florida.


Rudolph and Sletten Awarded $960M for New UCSF Benioff Children's Hospital

Construction work is expected to commence in September 2025 with substantial completion anticipated in 2031.


How Designers Create Welcoming Senior Care Communities

Risk assessments and cost analysis play a role in creating thriving communities.


Data-Driven Decisions: How Analytics Are Shaping Healthcare Facility Planning

Hospitals can use data to prioritize upgrades, extend building lifespans and maximize the impact of limited capital budgets.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.